Complementary and alternative medicine use ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Complementary and alternative medicine use in glioma patients in france
Auteur(s) :
Le Rhun, Emilie [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192 [PRISM]
Devos, Patrick [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Bourg, Veronique [Auteur]
Hôpital Pasteur [Nice] [CHU]
Darlix, Amelie [Auteur]
UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle [ICM]
Lorgis, Veronique [Auteur]
Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] [UNICANCER/CRLCC-CGFL]
Ahle, Guido [Auteur]
CH Colmar
Boone, Mathieu [Auteur]
CHU Amiens-Picardie
Taillandier, Luc [Auteur]
Centre de Recherche en Automatique de Nancy [CRAN]
Curtit, Elsa [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Gras, Louis [Auteur]
Lebrun Frenay, Christine [Auteur]
Hôpital Pasteur [Nice] [CHU]
Gramatzki, Dorothee [Auteur]
University hospital of Zurich [Zurich]
Ramirez, Carole [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Simon, Nicolas [Auteur]
Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
Weller, Michael [Auteur]
University hospital of Zurich [Zurich]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U 1192 [PRISM]
Devos, Patrick [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Bourg, Veronique [Auteur]
Hôpital Pasteur [Nice] [CHU]
Darlix, Amelie [Auteur]
UNICANCER - Institut régional du Cancer Montpellier Val d'Aurelle [ICM]
Lorgis, Veronique [Auteur]
Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] [UNICANCER/CRLCC-CGFL]
Ahle, Guido [Auteur]
CH Colmar
Boone, Mathieu [Auteur]
CHU Amiens-Picardie
Taillandier, Luc [Auteur]
Centre de Recherche en Automatique de Nancy [CRAN]
Curtit, Elsa [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Gras, Louis [Auteur]
Lebrun Frenay, Christine [Auteur]
Hôpital Pasteur [Nice] [CHU]
Gramatzki, Dorothee [Auteur]
University hospital of Zurich [Zurich]
Ramirez, Carole [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Simon, Nicolas [Auteur]
Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
Weller, Michael [Auteur]
University hospital of Zurich [Zurich]
Titre de la revue :
Journal of neuro-oncology
Nom court de la revue :
J. Neurooncol.
Numéro :
145
Pagination :
487-499
Date de publication :
2019-10-21
ISSN :
1573-7373
Mot(s)-clé(s) en anglais :
Acupuncture
Vitamins
Supplements
Magnetism
Diet
Brain
Vitamins
Supplements
Magnetism
Diet
Brain
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
OBJECTIVE: Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas.
METHODS: Questionnaires addressing CAM use were distributed to adult patients with ...
Lire la suite >OBJECTIVE: Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas. METHODS: Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0-2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted. RESULTS: Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures. CONCLUSIONS: CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.Lire moins >
Lire la suite >OBJECTIVE: Complementary and alternative medicine (CAM) use increases in cancer patients, including adult patients with diffuse gliomas. METHODS: Questionnaires addressing CAM use were distributed to adult patients with gliomas of WHO grades II-IV and ECOG performance score of 0-2 during hospital visits and filled in anonymously. The study was conducted in nine centers in France from May 2017 to May 2018. Descriptive cohort analyses and comparative analyses according to gender, age, WHO grade, and recurrent versus newly diagnosed disease were conducted. RESULTS: Two hundred twenty-seven questionnaires were collected; 135 patients (59%) were male. Median age was 48 years, 105 patients (46%) declared having glioblastoma, 99 patients (43%) declared having recurrent disease. Hundred-three patients (45%) had modified their alimentary habits after the glioma diagnosis. At the time of the questionnaire, 100 patients (44%) were on complementary treatment, mainly vitamins and food supplements, and 73 patients (32%) used alternative medicine approaches, mainly magnetism and acupuncture. In total, 154 patients (68%) declared using at least one of these approaches. Expenditures exceeding 100 € per month were reported by users in 14% for modification of alimentary habits, in 25% for complementary treatment, and in 18% for alternative medicines. All approaches were commonly considered as improving quality of life and experienced as efficient, notably those associated with more expenditures. CONCLUSIONS: CAM are frequently used by glioma patients in France. Underlying needs and expectations, as well as potential interactions with tumor-specific treatments, and financial and quality of life burden, should be discussed with patients and caregivers.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
INSERM
Université de Lille
INSERM
Université de Lille
Collections :
Équipe(s) de recherche :
Innovation/évaluation des dispositifs médicaux de perfusion
Date de dépôt :
2019-12-16T14:06:46Z
2021-06-07T07:50:43Z
2021-06-07T07:50:43Z